Individual results vary based on dose, starting weight, and lifestyle factors
The primary benefits of tirzepatideimproved glucose management and weight reductionremain the therapeutic focus, with creatine serving as an adjunct to support body composition goals when clinically appropriate
The proposed mechanisms range from well-validated (FDA-approved GLP-1 agonists for weight loss) to highly speculative (epitalon, thymosin alpha-1, MOTS-c) with limited or no human clinical validation
invest in healthcare provider training on indications, monitoring protocols, and contraindications
Weight health is changing quickly
Most patients notice reduced cravings and increased feelings of fullness within the first few weeks of treatment